| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing rasburicase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| rasburicase 1,5 mg pulver og solvens til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rasburicase (substance) |
Inferred relationship |
Some |
|
| rasburicase 7,5 mg pulver til infusionsvæske, rekonstitution + solvens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rasburicase (substance) |
Inferred relationship |
Some |
|
| Rasburicase 7.5mg infusion (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rasburicase (substance) |
Inferred relationship |
Some |
|
| Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| Rasburicase-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| Product containing only rasburicase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| Rasburicase only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| Rasburicase 1.5 mg powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
| Rasburicase 1.5 mg powder for solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Rasburicase (substance) |
Inferred relationship |
Some |
1 |
FHIR